Bruno Baillavoine - CEL SCI Independent Director
| CVM Stock | USD 1.50 0.02 1.32% |
Director
Mr. Bruno Baillavoine is an Independent Director of the Company. Mr. Baillavoine was the Director, Head of Pericles Group UK the subsidiary of the Paris based leading French consulting firm, Pericles Consulting Holdings SAS. Pericles is an expert in the field of Banking, Finance, Asset Management and Insurance with over 350 institutional clients. He has also been an advisor to the Board of CSL Inc, Combatives Sports League a US Mix Martial Arts company since 2017 and was appointed to the Board in 2019. Between 20102016, Mr. Baillavoine was a partner of Globomass Holdings Limited, a London, England based developer of renewable energy projects from concept through final operations. From 20122016 Mr. Baillavoine was the Executive Chairman of Globomass Holdings. Globomass was acquired by CleanBay Inc. in 2016. Mr. Baillavoine remains a significant sharehold in CleanBay Inc. Between 1978 and 1982 he was the marketing manager of Ravenhead Ltd., a manufacturer of glass tableware, and part of United Distillers Group . During this time Mr. Baillavoine became the UK Business Manager where he restored market share and profit for United Distillers. From 1982 to 1986 Mr. Baillavoine was Group Corporationrationrate Planning and Group Marketing Director for Prontaprint where he expanded the number of shops to 500 locations in four years since 2015.
| Age | 65 |
| Tenure | 9 years |
| Address | 8229 Boone Boulevard, Vienna, VA, United States, 22182 |
| Phone | 703 506 9460 |
| Web | https://cel-sci.com |
CEL SCI Management Efficiency
The company has Return on Asset of (0.5171) % which means that on every $100 spent on assets, it lost $0.5171. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.5825) %, meaning that it generated no profit with money invested by stockholders. CEL SCI's management efficiency ratios could be used to measure how well CEL SCI manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of April 2024, Return On Tangible Assets is likely to drop to -1. In addition to that, Return On Capital Employed is likely to drop to -1.52. At this time, CEL SCI's Debt To Assets are very stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mari Cano | Betterware De Mexico | N/A | |
| Laurie Knapp | Provident Bancorp | 56 | |
| Eduardo Szymanski | Betterware De Mexico | N/A | |
| Frank Cousins | Provident Bancorp | 55 | |
| Arthur Sullivan | Provident Bancorp | N/A | |
| Lisa DeStefano | Provident Bancorp | N/A | |
| Scott Lawrence | Home Federal Bancorp | 71 | |
| John Bosen | Provident Bancorp | 49 | |
| Andres Chevallier | Betterware De Mexico | 40 | |
| Richard Peeke | Provident Bancorp | 69 | |
| Walter Colquitt | Home Federal Bancorp | 72 | |
| Jay Gould | Provident Bancorp | N/A | |
| Clyde Patterson | Home Federal Bancorp | 74 | |
| Wayne Tatro | Provident Bancorp | 72 | |
| Thomas Trawick | Home Federal Bancorp | 48 | |
| Woodus Humphrey | Home Federal Bancorp | 77 | |
| Mark Harrison | Home Federal Bancorp | 58 | |
| David Herndon | Home Federal Bancorp | 79 | |
| Timothy Wilhite | Home Federal Bancorp | 48 | |
Management Performance
| Return On Equity | -1.58 | ||||
| Return On Asset | -0.52 |
CEL SCI Corp Leadership Team
Elected by the shareholders, the CEL SCI's board of directors comprises two types of representatives: CEL SCI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CEL. The board's role is to monitor CEL SCI's management team and ensure that shareholders' interests are well served. CEL SCI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CEL SCI's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maximilian Clara, Founder, Chairman and Pres | ||
| Peter Young, Independent Director | ||
| Gavin Windt, IR Contact Officer | ||
| Geert Kersten, Chief Executive Officer, Treasurer, Director | ||
| Robert Watson, Independent Director | ||
| Alexander Esterhazy, Independent Director | ||
| John Cipriano, Senior Vice President - Regulatory Affairs | ||
| Patricia Prichep, Senior Vice President - Operations, Corporate Secretary | ||
| Bruno Baillavoine, Independent Director | ||
| Geert Esq, Treasurer Officer | ||
| Eyal Talor, Chief Scientific Officer | ||
| Daniel Zimmerman, Senior Vice President - Research, Cellular Immunology |
CEL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CEL SCI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.58 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 89.51 M | ||||
| Shares Outstanding | 53.98 M | ||||
| Shares Owned By Insiders | 3.19 % | ||||
| Shares Owned By Institutions | 12.43 % | ||||
| Number Of Shares Shorted | 6.85 M | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 6.96 X | ||||
| Price To Sales | 11,797 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CEL SCI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CEL SCI's short interest history, or implied volatility extrapolated from CEL SCI options trading.
Pair Trading with CEL SCI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CEL SCI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will appreciate offsetting losses from the drop in the long position's value.Moving against CEL Stock
| 0.75 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.64 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.59 | ZNTL | Zentalis PharmaceuticalsL Financial Report 8th of May 2024 | PairCorr |
| 0.57 | JSPRW | Jasper Therapeutics | PairCorr |
| 0.52 | IMMP | Immutep Ltd ADR | PairCorr |
The ability to find closely correlated positions to CEL SCI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CEL SCI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CEL SCI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CEL SCI Corp to buy it.
The correlation of CEL SCI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CEL SCI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CEL SCI Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CEL SCI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for CEL Stock analysis
When running CEL SCI's price analysis, check to measure CEL SCI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CEL SCI is operating at the current time. Most of CEL SCI's value examination focuses on studying past and present price action to predict the probability of CEL SCI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CEL SCI's price. Additionally, you may evaluate how the addition of CEL SCI to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is CEL SCI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.63) | Return On Assets (0.52) | Return On Equity (1.58) |
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.